NCT07536321

Brief Summary

The goal of this observational study is to learn about the diagnostic and prognostic value of 18f fdg pet ct in follow up of colorectal cancer patients The main question it aims to answer is: Does pet ct have a role in treatment decision in colorectal cancer patients? Participants already be undergoing for pet ct as part of their follow up routine and will be followed up for 5 years.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for all trials

Timeline
59mo left

Started May 2026

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 2, 2026

Completed
15 days until next milestone

First Posted

Study publicly available on registry

April 17, 2026

Completed
14 days until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2030

Expected
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 5, 2031

Last Updated

April 17, 2026

Status Verified

April 1, 2026

Enrollment Period

4 years

First QC Date

April 2, 2026

Last Update Submit

April 11, 2026

Conditions

Rectal Cancer (Stage III)

Outcome Measures

Primary Outcomes (1)

  • Diagnostic value of pet ct in colorectal cancer

    Cross sectional

    2 years

Study Arms (1)

Group 1

Cross sectional

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Cross sectional

You may qualify if:

  • all patients with colorectal cancer recieved treatment

You may not qualify if:

  • pregnent women

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Rectal Neoplasms

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesRectal Diseases

Central Study Contacts

Waleed Ahmed Diab, Professor

CONTACT

+20 100 4242213wad4242@hotmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Sponsor

Study Record Dates

First Submitted

April 2, 2026

First Posted

April 17, 2026

Study Start

May 1, 2026

Primary Completion (Estimated)

April 20, 2030

Study Completion (Estimated)

March 5, 2031

Last Updated

April 17, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share